BioAro Launches PanOmiQ™ Research in Breakthrough for AI-Driven Drug Discovery and Multi-Omics

BioAro Launches PanOmiQ™ Research in Breakthrough for AI-Driven Drug Discovery and Multi-Omics

AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery.

UGenome AI & PlexusDx Announce Strategic Partnership to Deliver Pharmacogenomic Testing to Support Personalized Medicine - Journal of Cyber Policy

UGenome AI and PlexusDx partner to deliver DNA-based medication insights, advancing precision treatment for patients with rare and complex conditions. This partnership brings patients one step closer to faster, safer, and more effective treatment options guided by their genetic profile.” — Zachary Brooks, PhD, founder and CEO of UGenome AI ALPHARETTA, GA, UNITED STATES, June 16, 2025 /EINPresswire.com/ — UGenome AI, a leader in genomic software …